Why the study?
What are the long-term clinical outcomes and mortality rates in patients who undergo operation for idiopathic hypertrophic subaortic stenosis?
What are the long-term clinical outcomes and mortality rates in patients who undergo operation for idiopathic hypertrophic subaortic stenosis?
Surgical intervention for IHSS provides long-term symptomatic relief for most survivors, though it carries an 8% operative mortality and a persistent small annual risk of late death.
Answers are grounded in this paper and cite their sources.
Supports symptomatic benefit of IHSS surgery despite operative and late mortality risks; extends observational data but leaves open need for contemporary trials.
Long-term results of operation for IHSS were reviewed in 124 patients operated upon between 1960 and 1975. Most patients improved symptomatically and manifested marked reduction in LV outflow gradient at rest postoperatively. However, ten (8%) patients died of causes related to operation, 14 (12%) had persistent or recurrent severe functional limitation, and 11 (9%) died up to 13 years postoperatively due to hypertrophic cardiomyopathy. Overall annual mortality rate was 3.5% and was 1.8% for late deaths alone. Of 11 late postoperative deaths, six were sudden and five were due to chronic heart failure. Atrial fibrillation was significantly more common in patients who died late postoperatively than in survivors. Nine of the 11 late deaths had associated medical problems that may have contributed to their outcome. In conclusion, long-lasting clinical improvement occurred in most patients who survived operation for IHSS. However, 12% of patients deteriorated clinically over the 5.2 year average follow-up, and there is continued, small annual mortality.
No takes yet. Share an insight, caveat, or question.
Maron et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: